Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Flemming B. Sørensen
Programmed Death Ligand-1 Expression in Stage II Colon Cancer - Experiences From a Nationwide Populationbased Cohort
BMC Cancer
Cancer Research
Oncology
Genetics
Does Heterogeneity Matter in the Estimation of Tumour Budding and Tumour Stroma Ratio in Colon Cancer?
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Related publications
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
Journal of Cancer
Oncology
Programmed Death-Ligand 1 Expression and Its Correlation With Clinicopathological Parameters in Gallbladder Cancer
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors
Asian Pacific Journal of Cancer Prevention
The Prognostic Role of Immune Checkpoint Markers Programmed Cell Death Protein 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) in a Large, Multicenter Prostate Cancer Cohort
Oncotarget
Oncology
Clinicopathological Significance and Prognostic Implication of Programmed Death-1 Ligand 2 Expression in Colorectal Cancer
International Journal of Biological Markers
Oncology
Cancer Research
Clinical Biochemistry
Forensic Medicine
Medicine
Pathology
Prognostic Impact of CDX2 in Stage II Colon Cancer: Results From Two Nationwide Cohorts
British Journal of Cancer
Cancer Research
Oncology
P2.04-16 Correlation Between Programmed Death Ligand 1(pd-L1) Expression and Solid Component on HRCT in Stage I Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Clinical Cancer Research
Cancer Research
Oncology
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology
Cancer Research
Oncology